| Mr Mehdi Vazeen, MD | |
|
1104 N Division St, Carson City, NV 89703-3803 | |
| (775) 882-9123 | |
| Not Available |
| Full Name | Mr Mehdi Vazeen |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 32 Years |
| Location | 1104 N Division St, Carson City, Nevada |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982600516 | NPI | - | NPPES |
| 2013063 | Medicaid | NV |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | NV8939 (Nevada) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Center For Advanced Eye Care, Llc. | 7315843851 | 3 |
News Archive
Arrowhead Electronic Healthcare, LLC (Arrowhead) announced today its enhanced on-time, error-free guarantee program for all new ePRO projects using ePRO-LOG™ Smartphone, Web, Tablet or SMS. The guarantee specifies that the software configuration of every project will be completed per agreed upon schedule and will be free of configuration errors. If either condition is not fulfilled, customers will receive a full refund of software configuration fees upon request.
JPS Health Network (JPS), a Fort Worth, Texas-based healthcare system, has selected Order Optimizer to provide its evidence-based order set and clinical decision support platform. In support of the facility's top clinical priority for 2009, Order Optimizer was selected from a field of vendors for its renowned usability, extensive protocol library, and rapid implementation.
Nursing home residents are often cared for by a variety of health care professionals, including licensed nursing staff. Transfers to a hospital can result from multiple factors, such as recurrent falls or medication mismanagement.
Personalized Immunotherapy for Tumor Diseases and Beyond introduces personalized immunotherapy with multi-dimensional models of analysis to determine the best plan for the immunotherapy of patients.
GlaxoSmithKline plc and Genmab A/S announced today that the U.S. Food and Drug Administration (FDA) has approved a Supplemental Biologic License Application (sBLA) for the use of Arzerra® (ofatumumab), a CD20-directed cytolytic monoclonal antibody, in combination with chlorambucil for the treatment of previously untreated patients with chronic lymphocytic leukaemia (CLL) for whom fludarabine-based therapy is considered inappropriate.
› Verified 7 days ago
| Entity Name | Center For Advanced Eye Care, Llc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013009307 PECOS PAC ID: 7315843851 Enrollment ID: O20031208000467 |
News Archive
Arrowhead Electronic Healthcare, LLC (Arrowhead) announced today its enhanced on-time, error-free guarantee program for all new ePRO projects using ePRO-LOG™ Smartphone, Web, Tablet or SMS. The guarantee specifies that the software configuration of every project will be completed per agreed upon schedule and will be free of configuration errors. If either condition is not fulfilled, customers will receive a full refund of software configuration fees upon request.
JPS Health Network (JPS), a Fort Worth, Texas-based healthcare system, has selected Order Optimizer to provide its evidence-based order set and clinical decision support platform. In support of the facility's top clinical priority for 2009, Order Optimizer was selected from a field of vendors for its renowned usability, extensive protocol library, and rapid implementation.
Nursing home residents are often cared for by a variety of health care professionals, including licensed nursing staff. Transfers to a hospital can result from multiple factors, such as recurrent falls or medication mismanagement.
Personalized Immunotherapy for Tumor Diseases and Beyond introduces personalized immunotherapy with multi-dimensional models of analysis to determine the best plan for the immunotherapy of patients.
GlaxoSmithKline plc and Genmab A/S announced today that the U.S. Food and Drug Administration (FDA) has approved a Supplemental Biologic License Application (sBLA) for the use of Arzerra® (ofatumumab), a CD20-directed cytolytic monoclonal antibody, in combination with chlorambucil for the treatment of previously untreated patients with chronic lymphocytic leukaemia (CLL) for whom fludarabine-based therapy is considered inappropriate.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Mehdi Vazeen, MD 1104 N Division St, Carson City, NV 89703-3803 Ph: (775) 882-9123 | Mr Mehdi Vazeen, MD 1104 N Division St, Carson City, NV 89703-3803 Ph: (775) 882-9123 |
News Archive
Arrowhead Electronic Healthcare, LLC (Arrowhead) announced today its enhanced on-time, error-free guarantee program for all new ePRO projects using ePRO-LOG™ Smartphone, Web, Tablet or SMS. The guarantee specifies that the software configuration of every project will be completed per agreed upon schedule and will be free of configuration errors. If either condition is not fulfilled, customers will receive a full refund of software configuration fees upon request.
JPS Health Network (JPS), a Fort Worth, Texas-based healthcare system, has selected Order Optimizer to provide its evidence-based order set and clinical decision support platform. In support of the facility's top clinical priority for 2009, Order Optimizer was selected from a field of vendors for its renowned usability, extensive protocol library, and rapid implementation.
Nursing home residents are often cared for by a variety of health care professionals, including licensed nursing staff. Transfers to a hospital can result from multiple factors, such as recurrent falls or medication mismanagement.
Personalized Immunotherapy for Tumor Diseases and Beyond introduces personalized immunotherapy with multi-dimensional models of analysis to determine the best plan for the immunotherapy of patients.
GlaxoSmithKline plc and Genmab A/S announced today that the U.S. Food and Drug Administration (FDA) has approved a Supplemental Biologic License Application (sBLA) for the use of Arzerra® (ofatumumab), a CD20-directed cytolytic monoclonal antibody, in combination with chlorambucil for the treatment of previously untreated patients with chronic lymphocytic leukaemia (CLL) for whom fludarabine-based therapy is considered inappropriate.
› Verified 7 days ago
Dr. Michael Derek Westafer, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 3475 Gs Richards Blvd # 130, Carson City, NV 89703 Phone: 775-841-2000 Fax: 775-841-4200 | |
Dr. Robert Steven Wolff, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 3475 Gs Richards Blvd Ste 130, Carson City, NV 89703 Phone: 775-841-2000 Fax: 775-841-4200 | |
Dr. Michael John Fischer, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 3839 N Carson St, Carson City, NV 89706 Phone: 775-882-2988 Fax: 775-882-1726 | |
Mr. Ziqiang William Wu, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1104 N Division St, Carson City, NV 89703 Phone: 775-882-9123 | |
Annamieka Simmons Conway, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 1104 N Division St, Carson City, NV 89703 Phone: 775-882-9123 |